Medical News

RSS

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.

18 Mar 2010

French National Program finds significant decreases in the rates of HAIs since 2004

Researchers evaluating France's national infection control program for healthcare facilities found significant decreases in the rates of healthcare-associated infections (HAIs) since 2004. The drop in HAIs, including MRSA and surgical site infections, could be attributed to important changes in the national infection control system.

18 Mar 2010

Risk of hereditary form of bowel cancer: New preparation of omega-3 holds hope

A new preparation of an omega-3 polyunsaturated fatty acid found naturally in fish, offers hope for thousands of patients at risk of developing an inherited form of bowel cancer, a new study shows.

18 Mar 2010

EndoChoice launches new CEU Video Program for reprocessing endoscopes

EndoChoice, Inc. strengthens its position as the leader in endoscopy industry with the launch of a new CEU program and a complete line of products focused on efficient and effective endoscope reprocessing.

18 Mar 2010

Haemonetics extends previously announced cash tender offer for Global Med Technologies

Haemonetics Corporation today announced that it is extending its previously announced cash tender offer, through its wholly-owned subsidiary Atlas Acquisition Corp., for all outstanding shares of common and preferred stock of Global Med Technologies, Inc., until 12:00 midnight, Boston, Massachusetts time, on Wednesday, March 24, 2010.

18 Mar 2010

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.

18 Mar 2010

Forensic high-tech assistant Virtobot used to perform virtual autopsies

Virtobot is the name of the forensic high-tech helpmate used at the University of Bern's Institute of Forensic Medicine to perform virtual autopsies. Developed as part of the National Centre of Competence in Research, Co-Me the industrial robot provides forensic doctors with a high precision, three-dimensional image of cadavers.

18 Mar 2010

Teva Pharmaceutical Industries to acquire ratiopharm for €3.625 billion

Teva Pharmaceutical Industries Ltd. announced today that it has entered into a definitive agreement to acquire ratiopharm, Germany’s second largest generics producer and the sixth largest generic drug company worldwide, for an enterprise value of €3.625 billion. The transaction is subject to certain conditions including relevant regulatory approvals. On a pro forma basis, the combined company would have had 2009 revenues of $16.2 billion. Teva expects to complete the transaction by year-end 2010.

18 Mar 2010

Canadian Cancer Society launches daffodil pin campaign to fight back against cancer

The Canadian Cancer Society, BC and Yukon, is stepping up the fight by announcing today the launch of an inaugural daffodil pin - a badge of courage - as part of its annual Daffodil month campaign when canvassers go door-to-door.

18 Mar 2010

Concord Medical Services Holdings reports 24.3% increase in total net revenues for fourth-quarter 2009

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the fourth quarter and fiscal year ended December 31, 2009(1), and the appointment of Dr. Hongbin Cai as an independent board member.

18 Mar 2010

Evaluating functional significance of blockages in cardiac blood vessels with formulas from fluid mechanics

Improved care for cardiac patients and people with coronary artery disease is the goal of a new pilot study being led by engineering and medical researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs (VA) Medical Center.

18 Mar 2010

Researchers find some similarities between SPN and PET

Solid-pseudopapillary neoplasm (SPN) of the pancreas is relatively rare. There are some similarities between SPN and pancreatic endocrine tumor (PET), especially the non-functioning ones, in clinical and pathological manifestations.

18 Mar 2010

First Edition: March 18, 2010

Today's headlines indicate that Democrats are inching closer to securing the votes necessary to pass their health bill while the GOP is planning steps to bottle neck the measure's progress.

18 Mar 2010

Therapeutic may not be effective on trauma patients with undiagnosed Helicobacter infections

A Kansas State University study aimed at alleviating intestinal damage in trauma patients digressed to an important finding that could affect medication given to the individuals.

18 Mar 2010

Study finds the cost of cancer care is skyrocketing

USA Today: "The cost of cancer treatment is 'skyrocketing' — both for individual patients and the nation, a new analysis shows. From 1990 to 2008, spending on cancer care soared to more than $90 billion from $27 billion. The increase was driven by the rising costs of sophisticated new drugs, robotic surgeries and radiation techniques, as well as the growing number of patients who are eligible to take them, says Peter Bach of New York's Memorial Sloan-Kettering Cancer Cancer, co-author of an analysis in today's Journal of the American Medical Association.

18 Mar 2010

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

APCER Pharma announced that in the past three months it has further expanded its customer base and operations. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

18 Mar 2010

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.

18 Mar 2010

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

The U.S. 'race gap' in the commission of violent crime has narrowed substantially, yet persists in many cities - with murder arrest rates for African Americans out-distancing those for whites - concludes a new 80-city study by the University of Maryland, Florida State University and the University of Oregon.

18 Mar 2010

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

18 Mar 2010

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

The Health IT Now! Coalition hosted a panel discussion today with the Federal Communications Commission and a panel of experts to discuss the FCC's National Broadband Plan and its proposals to develop affordable access to broadband and healthcare.

18 Mar 2010

Medical News

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

French National Program finds significant decreases in the rates of HAIs since 2004

Risk of hereditary form of bowel cancer: New preparation of omega-3 holds hope

EndoChoice launches new CEU Video Program for reprocessing endoscopes

Haemonetics extends previously announced cash tender offer for Global Med Technologies

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

Forensic high-tech assistant Virtobot used to perform virtual autopsies

Teva Pharmaceutical Industries to acquire ratiopharm for €3.625 billion

Canadian Cancer Society launches daffodil pin campaign to fight back against cancer

Concord Medical Services Holdings reports 24.3% increase in total net revenues for fourth-quarter 2009

Evaluating functional significance of blockages in cardiac blood vessels with formulas from fluid mechanics

Researchers find some similarities between SPN and PET

First Edition: March 18, 2010

Therapeutic may not be effective on trauma patients with undiagnosed Helicobacter infections

Study finds the cost of cancer care is skyrocketing

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News